TrialProceedings of the National Academy of Sciences of the United States of America2020

Polygenic risk for skin autoimmunity impacts immune checkpoint blockade in bladder cancer.

Zia Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.